Talaan ng Balanse (Quarterly)
Neraca Alexandria Co. For Pharmaceuticals & Chemical Industries menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.
Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2023 06-30 |
2023 09-30 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | 83 | 68 | 68 | 52 | 81 | 81 | 55 | 154 | 91 | 136 | 150 | 238 | 238 | 171 |
| Change (%) | -17.76 | 0.53 | -23.76 | 55.57 | 0.00 | -32.47 | 180.80 | -41.13 | 50.56 | 10.10 | 58.77 | 0.00 | -28.04 | |
| Assets Current | 661 | 655 | 593 | 527 | 588 | 588 | 549 | 594 | 580 | 737 | 859 | 1,023 | 1,023 | 1,115 |
| Change (%) | -0.90 | -9.56 | -11.10 | 11.56 | 0.00 | -6.52 | 8.07 | -2.26 | 26.97 | 16.57 | 19.07 | 0.00 | 9.05 | |
| Assets | 866 | 858 | 834 | 793 | 876 | 876 | 831 | 875 | 923 | 1,084 | 1,241 | 1,406 | 1,406 | 1,489 |
| Change (%) | -0.95 | -2.78 | -4.85 | 10.45 | 0.00 | -5.16 | 5.29 | 5.46 | 17.43 | 14.50 | 13.28 | 0.00 | 5.95 | |
| Liabilities | 352 | 310 | 257 | 207 | 300 | 300 | 231 | 263 | 263 | 365 | 446 | 559 | 559 | 551 |
| Change (%) | -12.02 | -17.13 | -19.19 | 44.51 | 0.00 | -22.78 | 13.52 | 0.10 | 38.70 | 22.34 | 25.38 | 0.00 | -1.51 | |
| Equity | 514 | 548 | 577 | 586 | 577 | 577 | 600 | 613 | 660 | 719 | 795 | 847 | 847 | 939 |
| Change (%) | 6.62 | 5.32 | 1.53 | -1.59 | 0.00 | 3.99 | 2.12 | 7.76 | 8.97 | 10.52 | 6.49 | 0.00 | 10.88 | |
| Liabilities And Stock Equity | 866 | 858 | 834 | 793 | 876 | 876 | 831 | 875 | 923 | 1,084 | 1,241 | 1,406 | 1,406 | 1,489 |
| Change (%) | -0.95 | -2.78 | -4.85 | 10.45 | 0.00 | -5.16 | 5.29 | 5.46 | 17.43 | 14.50 | 13.28 | 0.00 | 5.95 | |
Source: Capital IQ
